John Seigne
Urology · Lebanon, NHNPI 1144242470
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $273 of the $331 with a category attached, or 82.5%. 6 manufacturers reported payments, led by EDAP Technomed Inc at 30.9% of the total. That places this record below the midpoint for urology clinicians in NH, where the typical reported total is $863.
Across 8 payments — averaging $41.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EDAP Technomed Inc$102
- Blue Earth Diagnostics$58
- AbbVie$54
- Urogen Pharma, Inc.$51
- Ferring Pharmaceuticals Inc.$36
- Janssen Scientific Affairs, LLC$30
Across 12 payments — averaging $2761.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$33K
What the payments were for
- Food & beverage$27383%
- Education$5817%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EDAP Technomed Inc | 3 | $102 |
| Blue Earth Diagnostics | 1 | $58 |
| AbbVie | 1 | $54 |
| Urogen Pharma, Inc. | 1 | $51 |
| Ferring Pharmaceuticals Inc. | 1 | $36 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
How this compares
$331 in reported general payments places this provider in the 25th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 26 | $18,731 |
| Tamsulosin Hcl | 76 | $1,199 |
| Finasteride | 28 | $448 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $340 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other urology in Lebanon
- Lori LernerLebanon$49K
- Roland ChenLebanon$3K
- Vernon PaisLebanon$2K
- Michael GrantLebanon$2K
- Nicholas MollLebanon$1K
- Rachel MosesLebanon$657
- Elizabeth GormleyLebanon$427
- David ChavezLebanon$278
- Einar SverrissonLebanon$168
- Ricky PhelpsLebanon$51
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.